Faculty of Pharmacy, University of Montreal, Montreal, Canada H3C 3J7.
Eur J Pharm Biopharm. 2010 Oct;76(2):147-58. doi: 10.1016/j.ejpb.2010.06.007. Epub 2010 Jun 19.
In the case of chronic therapies, the oral route is often the preferred route for drug administration given its acceptability and convenience. However, various factors which limit drug absorption through the gastro-intestinal (GI) mucosa contribute to restricting the bioavailability of the drug, that is, the actual amount which reaches the bloodstream. Among these factors, poor drug permeability through the GI mucosa and/or low aqueous solubility are of central importance. Polymeric micelles, which form upon self-assembly of amphiphilic macromolecules, can act as vehicles for the oral delivery of these drugs. This manuscript summarizes the literature in relation to the design of these micellar systems and their characterization with respect to drug loading and retention properties as well as the ability to withstand dissociation and drug discharge upon oral administration. Also, the role of certain polymers in improving drug absorption through the GI mucosa, either by increasing membrane permeability to the drug and/or carrier or by inhibiting drug efflux transporters in the GI mucosa, is discussed. Finally, this review reports other drug delivery strategies such as using bioadhesive polymers which may lengthen residence time in the GI tract and promote drug permeation, or rendering the polymeric micelles pH-sensitive in order to ensure drug release from the carrier at its site of absorption.
在慢性治疗的情况下,由于口服途径的可接受性和便利性,常常是药物给药的首选途径。然而,各种限制药物通过胃肠(GI)黏膜吸收的因素导致药物的生物利用度受到限制,即实际到达血液中的药物量。在这些因素中,药物通过 GI 黏膜的渗透性差和/或水溶解度低是至关重要的。两亲性大分子自组装形成的聚合物胶束,可以作为这些药物口服递送的载体。本文总结了与这些胶束系统的设计以及药物载药量和保留特性以及在口服给药时能够承受解离和药物释放的能力有关的文献。此外,还讨论了某些聚合物通过增加药物和/或载体对细胞膜的通透性或抑制 GI 黏膜中的药物外排转运体来提高药物在 GI 黏膜中的吸收的作用。最后,本综述还报道了其他药物递送策略,例如使用生物粘附聚合物,其可以延长在 GI 道中的停留时间并促进药物渗透,或者使聚合物胶束具有 pH 敏感性,以确保药物在吸收部位从载体中释放。